{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:21:14Z","timestamp":1773400874459,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12871-018-0583-8","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T10:57:40Z","timestamp":1537786660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Kai-Kai","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Qi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-4339","authenticated-orcid":false,"given":"Gui-Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"1","key":"583_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","volume":"63","author":"DF Zech","year":"1995","unstructured":"Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63(1):65\u201376.","journal-title":"Pain"},{"issue":"5 Suppl 2","key":"583_CR2","first-page":"25","volume":"13","author":"RK Portenoy","year":"1999","unstructured":"Portenoy RK. Managing cancer pain poorly responsive to systemic opioid therapy. Oncology (Williston Park). 1999;13(5 Suppl 2):25\u20139.","journal-title":"Oncology (Williston Park)"},{"key":"583_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/00000542-199605000-00029","volume":"84","author":"American Society of Anesthesiologists","year":"1996","unstructured":"American Society of Anesthesiologists. A report by the American Society of Anesthesiologists Task Force on pain management, Cancer pain section. Anesthesiology. 1996;84:1243\u201357.","journal-title":"Anesthesiology"},{"key":"583_CR4","unstructured":"World Health Organization (WHO) Expert Committee. Cancer pain relief and palliative care. Geneva: World Health Organization; 1990. Technical report series, No. 804."},{"key":"583_CR5","unstructured":"World Health Organization. Cancer pain relief, second edition, with a guide to opioid availability. Geneva: World Health Organization; 1996."},{"issue":"5","key":"583_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","volume":"84","author":"GW Hanks","year":"2001","unstructured":"Hanks GW, Conno F, Cherny N, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84(5):587\u201393.","journal-title":"Br J Cancer"},{"issue":"4","key":"583_CR7","first-page":"521","volume":"16","author":"B Ferrell","year":"1989","unstructured":"Ferrell B, Wisdom C, Wenzl C, Brown J. Effects of controlled-released morphine on quality of life for cancer pain. Oncol Nurs Forum. 1989;16(4):521\u20136.","journal-title":"Oncol Nurs Forum"},{"key":"583_CR8","unstructured":"Cancer Pain Relief: With a Guide to Opioid Availability, 2nd ed. Geneva, Switzerland: World Health Organization; 1996."},{"issue":"1","key":"583_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00520-005-0843-2","volume":"14","author":"J Riley","year":"2006","unstructured":"Riley J, Ross JR, Rutter D, et al. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer. 2006;14(1):56\u201364.","journal-title":"Support Care Cancer"},{"issue":"8","key":"583_CR10","first-page":"906","volume":"79","author":"AT Caraceni","year":"2013","unstructured":"Caraceni AT, Brunelli C, Rocco P, Minghetti P. Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010). Minerva Anestesiol. 2013;79(8):906\u201314.","journal-title":"Minerva Anestesiol"},{"key":"583_CR11","unstructured":"International Narcotics Control Board. Technical reports 2014. Available at: http:\/\/www.incb.org\/incb\/en\/ narcotic-drugs\/Technical_Reports\/narcotic_drugs_reports. html. Accessed 25 April 2016, 2015."},{"issue":"8","key":"583_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/archinte.166.8.837","volume":"166","author":"CM Reid","year":"2006","unstructured":"Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(8):837\u201343.","journal-title":"Arch Intern Med"},{"issue":"2","key":"583_CR13","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58\u201368.","journal-title":"Lancet Oncol"},{"issue":"1","key":"583_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0269216311418869","volume":"26","author":"SH Ahmedzai","year":"2012","unstructured":"Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone\/naloxone prolonged-release tablets in patients with moderate\/severe, chronic cancer pain. Palliat Med. 2012;26(1):50\u201360.","journal-title":"Palliat Med"},{"issue":"4","key":"583_CR15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.36076\/ppj.2014\/17\/329","volume":"17","author":"HG Kress","year":"2014","unstructured":"Kress HG, Koch ED, Kosturski H, et al. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain. Pain Physician. 2014;17(4):329\u201343.","journal-title":"Pain Physician"},{"issue":"8","key":"583_CR16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","volume":"12","author":"S Mercadante","year":"2008","unstructured":"Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12(8):1040\u20136.","journal-title":"Eur J Pain"},{"issue":"9","key":"583_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/AJP.0b013e3181ecd895","volume":"26","author":"S Mercadante","year":"2010","unstructured":"Mercadante S, Tirelli W, David F, et al. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain. 2010;26(9):794\u20137.","journal-title":"Clin J Pain"},{"key":"583_CR18","doi-asserted-by":"crossref","unstructured":"Silvestri B, Bandieri E, Del P S, et al. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.[J]. Clin Drug Investig. 2008;28(7):399.","DOI":"10.2165\/00044011-200828070-00001"},{"key":"583_CR19","volume":"5","author":"PJ Wiffen","year":"2014","unstructured":"Wiffen PJ, Derry S, Moore RA. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev. 2014;5:CD011056.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"583_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00002508-200309000-00002","volume":"19","author":"AR Gammaitoni","year":"2003","unstructured":"Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain. 2003;19(5):286\u201397.","journal-title":"Clin J Pain"},{"key":"583_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00520-008-0529-7","volume":"17","author":"M Delgado","year":"2009","unstructured":"Delgado M, Parsons HA, Li Z, Palmer JL, Bruera E. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009;17:573\u20139.","journal-title":"Support Care Cancer"},{"issue":"2","key":"583_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/082585970502100202","volume":"21","author":"F Strasser","year":"2005","unstructured":"Strasser F, Walker P, Bruera E. Palliative pain management: when both pain and suffering hurt. J Palliat Care. 2005;21(2):69\u201379.","journal-title":"J Palliat Care"},{"issue":"4","key":"583_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11916-010-0118-6","volume":"14","author":"TD Starr","year":"2010","unstructured":"Starr TD, Rogak LJ, Passik SD. Substance abuse in cancer pain. Curr Pain Headache Rep. 2010;14(4):268\u201375.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"583_CR24","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.36076\/ppj.2011\/14\/E85","volume":"14","author":"J Colson","year":"2011","unstructured":"Colson J, Koyyalagunta D, Falco FJ, Manchikanti L. A systematic review of observational studies on the effectiveness of opioid therapy for cancer pain. Pain Physician. 2011;14(2):E85\u2013102.","journal-title":"Pain Physician"},{"issue":"2","key":"583_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145\u201361.","journal-title":"Pain Physician"},{"issue":"3","key":"583_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.36076\/ppj.2011\/14\/249","volume":"14","author":"N Sehgal","year":"2011","unstructured":"Sehgal N, Smith HS, Manchikanti L. Peripherally acting opioids and clinical implications for pain control. Pain Physician. 2011;14(3):249\u201358.","journal-title":"Pain Physician"},{"key":"583_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"J Higgins","year":"2002","unstructured":"Higgins J, et al. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"583_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.","journal-title":"BMJ"},{"issue":"6","key":"583_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1185\/030079904125003854","volume":"20","author":"NY Gabrail","year":"2004","unstructured":"Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin. 2004;20(6):911\u20138.","journal-title":"Curr Med Res Opin"},{"key":"583_CR30","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2147\/JPR.S136937","volume":"10","author":"S Inoue","year":"2017","unstructured":"Inoue S, Saito Y, Tsuneto S, Aruga E, Ide A, Kakurai Y. A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a phase III study of EXtended-release HydromorphonE for cAncer pain reLief). J Pain Res. 2017;10:1953\u201362.","journal-title":"J Pain Res"},{"issue":"6","key":"583_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","volume":"27","author":"O Corli","year":"2016","unstructured":"Corli O, Floriani I, Roberto A, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107\u201315.","journal-title":"Ann Oncol"},{"issue":"2","key":"583_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpainsymman.2014.05.021","volume":"49","author":"J Riley","year":"2015","unstructured":"Riley J, Branford R, Droney J, et al. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial. J Pain Symptom Manag. 2015;49(2):161\u201372.","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"583_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jpain.2014.04.008","volume":"15","author":"S Yu","year":"2014","unstructured":"Yu S, Shen W, Yu L, Hou Y, Han J, Richards HM. Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study. J Pain. 2014;15(8):835\u201344.","journal-title":"J Pain"},{"issue":"6","key":"583_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jpainsymman.2016.05.030","volume":"52","author":"E Zecca","year":"2016","unstructured":"Zecca E, Brunelli C, Bracchi P, et al. Comparison of the tolerability profile of controlled-release oral morphine and oxycodone for Cancer pain treatment. An open-label randomized controlled trial. J Pain Symptom Manag. 2016;52(6):783\u201394. e6","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"583_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-3959(01)00324-4","volume":"93","author":"T Meuser","year":"2001","unstructured":"Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93(3):247\u201357.","journal-title":"Pain"},{"issue":"1\u20133","key":"583_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pain.2005.10.019","volume":"119","author":"TH Lindsay","year":"2005","unstructured":"Lindsay TH, Jonas BM, Sevcik MA, et al. Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression. Pain. 2005;119(1\u20133):233\u201346.","journal-title":"Pain"},{"issue":"1","key":"583_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(24)38873-1","volume":"295","author":"CK Nielsen","year":"2000","unstructured":"Nielsen CK, Ross FB, Smith MT. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the dark Agouti rat. J Pharmacol Exp Ther. 2000;295(1):91\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"583_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2007.03.022","volume":"132","author":"CK Nielsen","year":"2007","unstructured":"Nielsen CK, Ross FB, Lotfipour S, Saini KS, Edwards SR, Smith MT. Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain. 2007;132(3):289\u2013300.","journal-title":"Pain"},{"key":"583_CR39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/00000542-200610000-00027","volume":"105","author":"K Lemberg","year":"2006","unstructured":"Lemberg K, Kontinen V, Siskonen A, et al. Anti-nociception by spinal and systemic oxycodone: why does the route make a difference? Anesthesiology. 2006;105:801\u201312.","journal-title":"Anesthesiology"},{"issue":"8","key":"583_CR40","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.bjp.0705763","volume":"141","author":"PJ Riviere","year":"2004","unstructured":"Riviere PJ. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol. 2004;141(8):1331\u20134.","journal-title":"Br J Pharmacol"},{"key":"583_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1124\/jpet.104.065391","volume":"310","author":"TW Vanderah","year":"2004","unstructured":"Vanderah TW, Schteingart CD, Trojnar J, et al. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): a peripheral efficacious k-opioid agonist with unprecedented selectivity. J Pharmacol Exp Ther. 2004;310:326\u201333.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"583_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/00365520601014414","volume":"42","author":"C Staahl","year":"2007","unstructured":"Staahl C, Dimcevski G, Andersen SD, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol. 2007;42(3):383\u201390.","journal-title":"Scand J Gastroenterol"},{"issue":"1\u20132","key":"583_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pain.2006.02.006","volume":"123","author":"C Staahl","year":"2006","unstructured":"Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain. 2006;123(1\u20132):28\u201336.","journal-title":"Pain"},{"issue":"3","key":"583_CR44","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.094276","volume":"316","author":"EM Peckham","year":"2006","unstructured":"Peckham EM, Traynor JR. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J Pharmacol Exp Ther. 2006;316(3):1195\u2013201.","journal-title":"J Pharmacol Exp Ther"},{"key":"583_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pain.2007.09.027","volume":"132","author":"E Kalso","year":"2007","unstructured":"Kalso E. How different is oxycodone from morphine? Pain. 2007;132:227\u20138.","journal-title":"Pain"},{"issue":"3","key":"583_CR46","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)24553-0","volume":"272","author":"LR Flores","year":"1995","unstructured":"Flores LR, Wahl SM, Bayer BM. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. J Pharmacol Exp Ther. 1995;272(3):1246\u201351.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"583_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-5728(00)00401-X","volume":"111","author":"ID Welters","year":"2000","unstructured":"Welters ID, Menzebach A, Goumon Y, et al. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and mu(3) opiate receptor-dependent mechanism. J Neuroimmunol. 2000;111(1\u20132):139\u201345.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"583_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjp.0701138","volume":"121","author":"P Sacerdote","year":"1997","unstructured":"Sacerdote P, Manfredi B, Mantegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol. 1997;121(4):834\u201340.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"583_CR49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-3565(25)19959-X","volume":"252","author":"CC Chao","year":"1990","unstructured":"Chao CC, Sharp BM, Pomeroy C, Filice GA, Peterson PK. Lethality of morphine in mice infected with toxoplasma gondii. J Pharmacol Exp Ther. 1990;252(2):605\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"583_CR50","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/infdis\/167.6.1281","volume":"167","author":"JM Risdahl","year":"1993","unstructured":"Risdahl JM, Peterson PK, Chao CC, Pijoan C, Molitor TW. Effects of morphine dependence on the pathogenesis of swine herpesvirus infection. J Infect Dis. 1993;167(6):1281\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"583_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000139266","volume":"50","author":"PT Thomas","year":"1995","unstructured":"Thomas PT, Bhargava HN, House RV. Immunomodulatory effects of in vitro exposure to morphine and its metabolites. Pharmacology. 1995;50(1):51\u201362.","journal-title":"Pharmacology"},{"issue":"5","key":"583_CR52","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1567-5769(01)00020-0","volume":"1","author":"KA Carrigan","year":"2001","unstructured":"Carrigan KA, Lysle DT. Morphine-6b-glucuronide induces potent immunomodulation. Int Immunopharmacol. 2001;1(5):821\u201331.","journal-title":"Int Immunopharmacol"},{"issue":"1\u20132","key":"583_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pain.2006.10.023","volume":"130","author":"CC Reyes-Gibby","year":"2007","unstructured":"Reyes-Gibby CC, Shete S, Rakvag T, et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. 2007;130(1\u20132):25\u201330.","journal-title":"Pain"},{"issue":"6","key":"583_CR54","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/cncr.23292","volume":"112","author":"JR Ross","year":"2008","unstructured":"Ross JR, Riley J, Taegetmeyer AB, et al. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer. 2008;112(6):1390\u2013403.","journal-title":"Cancer"},{"issue":"2","key":"583_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejpain.2004.05.008","volume":"9","author":"UM Stamer","year":"2005","unstructured":"Stamer UM, Bayerer B, Stuber F. Genetics and variability in opioid response. Eur J Pain. 2005;9(2):101\u20134.","journal-title":"Eur J Pain"},{"issue":"3","key":"583_CR56","first-page":"209","volume":"7","author":"RS Sinatra","year":"1988","unstructured":"Sinatra RS, Hyde NH, Harrison DM. Oxymorphone revisited. Semin Anesth. 1988;7(3):209\u201315.","journal-title":"Semin Anesth"},{"issue":"13","key":"583_CR57","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1158\/1078-0432.CCR-10-3028","volume":"17","author":"A Galvan","year":"2011","unstructured":"Galvan A, Skorpen F, Klepstad P, et al. Multiple loci modulate opioid therapy response for cancer pain. Clin Cancer Res. 2011;17(13):4581\u20137.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"583_CR58","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/bcp.12008","volume":"75","author":"JM Droney","year":"2013","unstructured":"Droney JM, Gretton SK, Sato H, et al. Analgesia and central side-effects: two separate dimensions of morphine response. Br J Clin Pharmacol. 2013;75(5):1340\u201350.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"583_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1399-0004.2012.01923.x","volume":"82","author":"R Branford","year":"2012","unstructured":"Branford R, Droney J, Ross JR. Opioid genetics: the key to personalized pain control? Clin Genet. 2012;82(4):301\u201310.","journal-title":"Clin Genet"},{"issue":"6","key":"583_CR60","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.clon.2011.04.015","volume":"23","author":"J Droney","year":"2011","unstructured":"Droney J, Riley J, Ross JR. Evolving knowledge of opioid genetics in cancer pain. Clin Oncol (R Coll Radiol). 2011;23(6):418\u201328.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"583_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","volume":"73","author":"T Heiskanen","year":"1997","unstructured":"Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer related pain. Pain. 1997;73(1):37\u201345.","journal-title":"Pain"},{"issue":"3","key":"583_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","volume":"2","author":"P Mucci-LoRusso","year":"1998","unstructured":"Mucci-LoRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain. 1998;2(3):239\u201349.","journal-title":"Eur J Pain"},{"issue":"10","key":"583_CR63","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","volume":"16","author":"E Bruera","year":"1998","unstructured":"Bruera E, Belzile M, Pituskin E, et al. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol. 1998;16(10):3222\u20139.","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1186\/s12871-018-0630-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000}}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-018-0583-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T18:29:58Z","timestamp":1755628198000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-018-0583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1186\/s12871-018-0583-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12871-018-0630-5","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"3 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After publication of this article [1], the authors noted that the corresponding email address is incorrect.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"132"}}